U.S. FDA Leadership from Three Centers and OII Headline the Center Office Updates Session of the 2026 PDA/FDA Joint Regulatory Conference

Summary

The PDA announced that senior FDA leaders from the centers for drugs, biologics, and veterinary medicine, along with the Office of Inspections and Investigations, will participate in a plenary session at the 2026 PDA/FDA Joint Regulatory Conference on September 14 in Washington, D.C.